Africa Corporate Wellness Market, by End User, 2018-2027
| Label | USD Million |
|---|---|
| 2018 | 452.339122683942 USD Million |
| 2019 | 441.137066908723 USD Million |
| 2020 | 444.574839128801 USD Million |
| 2021 | 454.733178153485 USD Million |
| 2022 | 469.179581605319 USD Million |
| 2023 | 488.10256901359 USD Million |
| 2024 | 509.433339621806 USD Million |
| 2025 | 533.524555278486 USD Million |
| 2026 | 560.79449551368 USD Million |
| 2027 | 591.741609507102 USD Million |
| 2028 | 629.222662853948 USD Million |
| 2029 | 671.994498720027 USD Million |
| 2030 | 720.991706792019 USD Million |
| 2031 | 777.353221971172 USD Million |
| 2032 | 842.475014832925 USD Million |
Data Source: Wantstats Repository
Market Dynamics
The global market for GCC plasma fractionation has grown exponentially in recent years, driven by the growth of the GCC countries, especially in the Middle East and North Africa (MENA) region. The GCC countries have one of the most advanced healthcare systems in the world and are increasingly investing in healthcare infrastructure, making them one of the fastest growing region for medical investments. This is reflected in the growing demand for GCC plasma fractionation, which is expected to remain strong over the forecast period (2018 to 2032). The need for plasma fractionation is driven by the rising prevalence of certain conditions such as HIV/AIDS, haemophilia, and other blood disorders, which are commonly treated with blood products, such as albumin and immunoglobulins, which can be extracted from human plasma. GCC countries have significant resources for plasma fractionation, providing a strong growth driver to the growing industry. When it comes to GCC plasma fractionation, the majority of the market is held by the top players including B Braun, Biomarin, CSL Behring, and Grifols. These companies are known to have specialized technology, reliable and efficient operations, and global reach, which allows them to stay competitive in the market.
Moreover, these companies are also coming up with innovative and cutting-edge technologies to reduce cost and improve efficiency, thus strengthening their leading position in the GCC plasma fractionation market. In terms of government activities, GCC countries are constantly spending heavily in healthcare infrastructure, with a special focus on utilitarian and preventive wellness programs to control the rising prevalence of infectious diseases. This is expected to fuel the demand for GCC plasma fractionation. On the other hand, stringent regulation on quality, safety, and efficacy is also expected to slow down the growth of the market. Overall, the GCC plasma fractionation market is expected to register moderate to high growth over the coming years, owing to increasing awareness and prevalence of certain diseases, government initiatives, and rising investments in healthcare infrastructure. With leading players in the market continually coming up with new technological advancements, affordability and improved efficiency is also expected to further bolster the market growth.
Research Methodology
Figures reflect Wantstats’ original market research and forecasting models, compiled as part of the Wantstats research archive and published in 2023.
Unlock the Full Data
Get This Chart
Access the complete chart and underlying data to support your research, analysis, and business decisions.
Powering the world's best teams.
From next-gen startups to established enterprises.
Get in Touch
Let's work together
support@wantstats.comSee our work in action
Start your data driven journey with us!
What our clients say
Trusted by forward-thinking businesses
for data-driven intelligence



